Salvina Therapeutics
Salvina Therapeutics is developing antibodies with a novel approach for targeting TNF and TNF superfamily members with the aim of improving their safety and efficacy, and facilitating the generation of novel bispecific therapies.
Date, time and room information
May 5, 15:00 - 15:15, room Singapore
Category
Emerging biotech company
Speaker information
| Name | Position | Institution |
|---|---|---|
| Mattias Ivarsson | CEO |
